Scientists “Turbocharge” T-Cells to Attack Prostate Cancer
New findings could lead to safer, more effective T cell therapies for prostate cancer and other solid tumors.
Dean Gehring, former Executive Vice President and Chief Technical Officer at Newmont Corporation, shares insights on using visual tools to communicate effectively in business.